The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers. Subscribe to our ...

Amid ongoing controversy over 340B drug discounts, a sweeping review suggests the program is doing what it was intended to do: generate revenue for hospitals, clinics and pharmacies by requiring ...

​A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

It's the latest evidence of rising spending in the drug discount program as regulators attempt to tamp down on growth in 340B.

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...

Outpatient drug purchases under the 340B Drug Pricing Program crossed the $100 billion mark across 2025, a roughly 23% ...

Henry Ford Health has filed a lawsuit against CVS Health (NYSE:CVS) alleging fraudulent reimbursement practices tied to the ...

Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics.

Hospitals in the 340B program will get $9 billion under a proposed rule to make them whole in a lump sum payment, according to the Centers for Medicare and Medicaid Services. An estimated $9 billion ...

The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual ...

Long-term 340B participation is linked to stronger financial assets, with much of the program’s recent growth flowing ...